Crushing tablets or sprinkling capsules: Implications for clinical strategy and study performance based on BE studies of rivaroxaban and deferasirox

Documenti analoghi

• Development of immediate‐release formulation with reliable absorption of rivaroxaban in various meal regimes
  di: Jan Bosák, et al.
  Pubblicazione: (2024)
• A case study of inclusion of rural populations in research: Implications for science and health equity
  di: Devon Noonan, et al.
  Pubblicazione: (2024)
• QPGx‐CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies
  di: Rania Abdel‐latif, et al.
  Pubblicazione: (2024)
• Sources of pharmacokinetic and pharmacodynamic variability and clinical pharmacology studies of antiseizure medications in the pediatric population
  di: Patricia D. Maglalang, et al.
  Pubblicazione: (2024)
• Exploring the discrepancies between clinical trials and real‐world data: A small‐cell lung cancer study
  di: Luca Marzano, et al.
  Pubblicazione: (2024)